1. Bowen R, Chavira DA, Bailey K, et al. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008;157:201-9.
2. Walkup JT, Labellarte MJ, Riddle MA, et al. Searching for moderators and mediators of pharmacological treatment in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42:13-21.
3. Wiesegger G, Kienbacher C, Pellegrini E, et al. Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders. Neuropsychiatr 2007;21:187-206.
4. Abikoff H, McGough J, Vitiello B, et al. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 2005;44:418-27.
5. Compendium of pharmaceuticals and specialties. Ottawa, Canada: Canadian Pharmacists Association; 2008.
6. Goez H, Back-Bennet O, Zelnik N. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J Child Neurol 2007;22:538-42.
7. Wells KC, Pelham WE, Kotkin RA, et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol 2000;28:483-505.
8. March JS, Swanson JM, Arnold EL, et al. Anxiety as a predictor and outcome variable in the Multimodal Treatment Study of Children with ADHD (MTA). J Abnorm Child Psychol 2000;28:527-41.
9. Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without anxiety. J Am Acad Child Adolesc Psychiatry 1995;34:886-96.
10. Manassis K, Tannock R, Young A, Francis-John S. Cognition in anxious children with attention deficit hyperactivity disorder: a comparison with clinical and normal children. Behav Brain Funct 2007;3-4.
11. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 2007;46:1119-27.
12. Compton SN, March JS, Brent D, et al. Cognitive behavioural psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004;43:930-59.
13. Manassis K, Mendlowitz SL, Scapillato D, et al. Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. J Am Acad Child Adolesc Psychiatry 2002;41:1423-30.
14. Arnold LE, Abikoff HB, Cantwell DP, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry 1997;54:865-70.
15. Kagan J, Reznick JS, Snidman N. Biological basis of childhood shyness. Science 1990;240:167-71.
16. Van Cleave J, Leslie LK. Approaching ADHD as a chronic condition: implications for long-term adherence. Pediatr Ann 2008;37:19-26.
17. Manassis K, Monga S. therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions. J Am Acad Child Adolesc Psychiatry 2001;40:115-7.
